Stay updated on Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Sign up to get notified when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.

Latest updates to the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page
- Check6 days agoChange DetectedThe page revision marker was updated from v3.5.3 to v3.5.4, signaling a metadata update. There is no evident change to the study details or content from this update.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows a revision update from v3.5.2 to v3.5.3, indicating a minor maintenance update that does not change substantive study details.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check49 days agoChange DetectedThe study status was updated from enrollment by invitation to Completed, with the completion date recorded as 2026-03-24 and the update posted 2026-03-27. The enrollment-by-invitation note and related estimated dates were removed.SummaryDifference0.5%

- Check56 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. This indicates a newer version of the study details page.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combo Study of SV-BR-1-GM With Retifanlimab Clinical Trial page.